GlaxoSmithKline has agreed to pay $40 million to settle a Paxil class action lawsuit, which claims that the drug maker promoted the antidepressant for use in children without disclosing information about Paxil side effects and evidence that the drug is not effective in kids. The Paxil settlement will refund insurers for benefits paid for use of the drug by children and teenagers. Continued

